M&A Deal Summary

Novartis Acquires Alcon

On December 15, 2010, Novartis acquired medical products company Alcon

Acquisition Highlights
  • This is Novartis’ 1st transaction in the Medical Products sector.
  • This is Novartis’ 6th transaction in the United States.
  • This is Novartis’ 1st transaction in Texas.

M&A Deal Summary
Date 2010-12-15
Target Alcon
Sector Medical Products
Buyer(s) Novartis
Deal Type Merger
Advisor(s) Cravath, Swaine & Moore
Homburger (Legal)

Target

Alcon

Fort Worth, Texas, United States
Alcon, Inc. is an eye care company that researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contacts lens solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon is located in Fort Worth, Texas and was formed in 1945.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Novartis

Basel, Switzerland
Category Company
Founded 1996
Sector Life Science
Employees104,323
Revenue 46.7B USD (2023)
DESCRIPTION
Novartis' corporate campus in Basel, Switzerland.
Novartis' corporate campus in Basel, Switzerland.

Novartis is a global healthcare and pharmaceutical enterprise dedicated to advancing medical innovation and enhancing patient well-being. Renowned for its pioneering research and development efforts, Novartis has a comprehensive portfolio encompassing groundbreaking pharmaceuticals, generic medications, biosimilars, and eye care solutions. Novartis was founded in 1996 and is based in Basel, Switzerland.

DEAL STATS #
Overall 6 of 32
Sector (Medical Products) 1 of 3
Type (Merger) 1 of 1
State (Texas) 1 of 3
Country (United States) 6 of 24
Year (2010) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-12-23 Corthera

San Francisco, California, United States

Corthera Inc. is a biopharmaceutical company based in San Francisco. Corthera develops relaxin, a treatment for patients with acute decompensated heart failure.

Buy $120M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-04 Genoptix

Carlsbad, California, United States

Genoptix, Inc. is one of the largest hematopathology testing laboratories in the U.S., providing thousands of oncologists and pathologists across the United States with comprehensive testing solutions in hematology and solid tumor molecular profiling. Genoptix, Inc. was founded in 1999 and is based in Carlsbad, California.

Buy $470M
Mergr

Product

Company

Legal